BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4990554)

  • 21. Clinical use of antilymphoblast serum.
    Najarian JS; Merkel FK; Moore GE; Good RA; Aust JC
    Transplant Proc; 1969 Mar; 1(1):460-2. PubMed ID: 5002662
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.
    Kashiwagi N; Brantigan CO; Brettschneider L; Groth CG; Starzl TE
    Ann Intern Med; 1968 Feb; 68(2):275-86. PubMed ID: 4181614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels.
    Jones VE; Lance EM; Abbosh J; Graves HE
    Clin Exp Immunol; 1975 Jul; 21(1):13-22. PubMed ID: 810281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of tolerance to antilymphocyte globulin in man.
    Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL
    Transplant Proc; 1971 Mar; 3(1):754-7. PubMed ID: 4937967
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma equine gamma-globulin in tolerant adult dogs given anti-lymphocyte globulin.
    Sichuk G; Shiu MH; Csurny RW; Fortner JG
    Nat New Biol; 1971 Jun; 231(22):151-2. PubMed ID: 4997055
    [No Abstract]   [Full Text] [Related]  

  • 26. [Renal transplantation. Clinical experience with antilymphocyte serum].
    Traeger J; Fries D
    J Urol Nephrol (Paris); 1969 Dec; 75(12):Suppl 12:200+. PubMed ID: 4989751
    [No Abstract]   [Full Text] [Related]  

  • 27. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of antilymphocyte globulin in kidney transplantation in the early postoperative period].
    Radzivil GG; Lobanova ED; L'vitsyna GM; Kutasova IV; Vasina TA
    Klin Med (Mosk); 1975 Mar; 53(3):26-33. PubMed ID: 1090779
    [No Abstract]   [Full Text] [Related]  

  • 29. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts.
    MacDonald AS; Alexander JL; Busch GJ; Murray JE
    Surg Forum; 1969; 20():306-7. PubMed ID: 4192215
    [No Abstract]   [Full Text] [Related]  

  • 30. Cross-reactivity studies of horse, goat and rabbit anti-lymphocyte globulin.
    Ameniya H; Kashiwagi N; Putnam CW; Starzl TE
    Clin Exp Immunol; 1970 Feb; 6(2):279-89. PubMed ID: 4985160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of antilymphocyte globulin after cadaveric renal transplantation.
    Doak PB; Dalton NT; Meredith J; Montgomerie JZ; North JD
    Br Med J; 1969 Nov; 4(5682):522-5. PubMed ID: 4901345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary studies on antithymocyte globulin.
    Orlowski T; SkopiƄska E; Kossowska-Paul B; Wasik M; Wojtulewicz-Kurkus J; Klopotowska E; Tupalska B; Filipowicz Z
    Pol Med J; 1971; 10(2):400-7. PubMed ID: 4997629
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterologous antilymphocyte serum. Influence of immunogenicity on immunosuppressive properties.
    Raju S; Grogan JB
    Transplantation; 1969 Nov; 8(5):695-703. PubMed ID: 4994822
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunologic responses of graft recipients to antilymphocyte globulin: effect of prior treatment with aggregate-free gamma globulin.
    Weksler ME; Bull G; Schwartz GH; Stenzel KH; Rubin AL
    J Clin Invest; 1970 Aug; 49(8):1589-95. PubMed ID: 4194090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antilymphocyte globulin today].
    Brendel W
    Munch Med Wochenschr; 1973 Feb; 115(7):241-8. PubMed ID: 4632641
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-lymphocytic globulin in canine renal allotransplantation. I. Histologic and immunohistologic findings for two preparations given by subcutaneous and intravenous routes.
    Collste LG; Wasserman J; Bergstrand A; Groth CG
    Acta Chir Scand; 1972; 138(7):655-60. PubMed ID: 4566003
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical experience with horse antihuman ALG.
    Starzl TE; Groth CG; Kashiwagi N; Putnam CW; Corman JL; Halgrimson CG; Penn I
    Transplant Proc; 1972 Dec; 4(4):491-5. PubMed ID: 4566793
    [No Abstract]   [Full Text] [Related]  

  • 38. ALG treatment of Rhesus monkeys. Attempts to reduce complications by the induction of tolerance.
    Balner H; Yron I; Dersjant H; Zaalberg O; Betel I
    Transplantation; 1970 Nov; 10(5):416-24. PubMed ID: 4992451
    [No Abstract]   [Full Text] [Related]  

  • 39. The monkey skin graft model as an assay of human antilymphocyte globulin.
    Kobayashi K; Hricko GM; Reisner GS; Levin L; Latham WC; Lukl P; Busch GJ; Birtch AG
    Transplantation; 1972 Dec; 14(6):698-704. PubMed ID: 4630076
    [No Abstract]   [Full Text] [Related]  

  • 40. Autologous anti-I and anti-M following liver transplant.
    Tegoli J; Harris JP; Nichols ME; Marsh WL; Reid ME
    Transfusion; 1970; 10(3):133-6. PubMed ID: 4987191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.